Pregabalin Compared to Gabapentin for Pain Control in Lumbar Disc Surgery

Overview[ - collapse ][ - ]

Purpose Pregabalin is claimed to have superior analgesic effect at lower doses and better pharmacological profile as compared to gabapentin esp. in perioperative pain control after major surgeries like intervertebral disc surgery. The investigators found that pregabalin is equivalent to gabapentin for relief of post-operative pain at a lower dose in patients undergoing intervertebral disc surgery.
ConditionIntervertebral Disc Prolapse
InterventionDrug: Pregabalin
Drug: Gabapentin
PhasePhase 3
SponsorAga Khan University
Responsible PartyAga Khan University
ClinicalTrials.gov IdentifierNCT02120703
First ReceivedApril 19, 2014
Last UpdatedApril 22, 2014
Last verifiedApril 2014

Tracking Information[ + expand ][ + ]

First Received DateApril 19, 2014
Last Updated DateApril 22, 2014
Start DateFebruary 2011
Estimated Primary Completion DateOctober 2011
Current Primary Outcome MeasuresPain [Time Frame: 7 days] [Designated as safety issue: No]Pain measurement using Visual Analogue Score at 24 hours and 7th day of surgery
Current Secondary Outcome MeasuresNot Provided

Descriptive Information[ + expand ][ + ]

Brief TitlePregabalin Compared to Gabapentin for Pain Control in Lumbar Disc Surgery
Official TitleGabapentin vs. Pregabalin for Post Operative Pain in Lumbar Microdiscectomy: a Randomized Controlled Trial.
Brief Summary
Pregabalin is claimed to have superior analgesic effect at lower doses and better
pharmacological profile as compared to gabapentin esp. in perioperative pain control after
major surgeries like intervertebral disc surgery.

The investigators found that pregabalin is equivalent to gabapentin for relief of
post-operative pain at a lower dose in patients undergoing intervertebral disc surgery.
Detailed DescriptionNot Provided
Study TypeInterventional
Study PhasePhase 3
Study DesignAllocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care
ConditionIntervertebral Disc Prolapse
InterventionDrug: Pregabalin
Pregablin 75 mg per oral two times a day
Drug: Gabapentin
Gabapentin 200 mg twice daily per oral
Study Arm (s)
  • Active Comparator: gabapentin
  • Active Comparator: Pregabalin

Recruitment Information[ + expand ][ + ]

Recruitment StatusCompleted
Estimated Enrollment78
Estimated Completion DateOctober 2011
Estimated Primary Completion DateOctober 2011
Eligibility Criteria
Inclusion Criteria:

- 30-60 years age

- Any gender

- elective micro discectomy for intervertebral disc prolapse

Exclusion Criteria:

1. micro discectomy at two or more vertebral levels,

2. Instrumentation i.e. pedicle screw fixation, hooks etc.,

3. history of steroids or alcohol use,

4. Multiple co-morbids i.e. renal failure, chronic liver disease,

5. use of anticonvulsant drugs,

6. Spinal deformity,

7. Obesity (BMI >30), 8) inability to understand and respond VAS and

9) patients with known allergy to GABA analogues.
GenderBoth
Ages30 Years
Accepts Healthy VolunteersNo
ContactsNot Provided
Location CountriesPakistan

Administrative Information[ + expand ][ + ]

NCT Number NCT02120703
Other Study ID Numbers173-SUR-ERC-10
Has Data Monitoring CommitteeNo
Information Provided ByAga Khan University
Study SponsorAga Khan University
CollaboratorsNot Provided
Investigators Principal Investigator: Mohsin Qadeer, FCPS The Aga Khan University Hospital, Karachi, Pakistan
Verification DateApril 2014

Locations[ + expand ][ + ]

The Aga Khan University Hospital
Karachi, Sind, Pakistan, 75300